ONCOLOGY Vol 37, Issue 4
Advancement Continues in ‘Go-to’ Strategies for Gynecologic Cancer
April 28th 2023ArticleInterview
“Even in well-resourced countries, there are disparities in exposure to treatments; some of these are rooted deeply in social determinants of health and represent a very complex problem of providing equal access.”
Daniel V. T. Catenacci, MD;Yoon-Koo Kang, MD, PhD;Hope E. Uronis, MD, MHS;Keun-Wook Lee, MD, PhD;Matthew C. H. Ng, MD;Peter C. Enzinger, MD;Se Hoon Park, MD, PhD;Philip J. Gold, MD;Jill Lacy, MD;Howard S. Hochster, MD;Sang Cheul Oh, MD, PhD;Yeul Hong Kim, MD, PhD;Kristen A. Marrone, MD;Ronan J. Kelly, MD;Rosalyn A. Juergens, MD;Jong Gwang Kim, MD, PhD;Thierry Alcindor, MD, MSc;Sun Jin Sym, MD, PhD;Eun-Kee Song, MD, PhD;Cheng Ean Chee, MD;Yee Chao, MD, PhD;Sunnie Kim, MD;Do-Youn Oh, MD, PhD;Jennifer Yen, PhD;Justin I. Odegaard, MD, PhD;Errin Lagow, PhD;Daner Li, MS;Jichao Sun, PhD;Patrick Kaminker, PhD;Paul A. Moore, PhD;Minori Koshiji Rosales, MD, PhD;Haeseong Park, MD, MPH
April 27th 2023ArticleOriginal Research
Daniel V. T. Catenacci, MD, and colleagues present findings from a study of circulating tumor DNA as a predictive biomarker for gastric and gastroesophageal cancer.
